209 related articles for article (PubMed ID: 30420360)
1. Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice.
Wilson CD; Tai S; Ewing L; Crane J; Lockhart T; Fujiwara R; Radominska-Pandya A; Fantegrossi WE
J Pharmacol Exp Ther; 2019 Feb; 368(2):146-156. PubMed ID: 30420360
[TBL] [Abstract][Full Text] [Related]
2. Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice.
Wilson CD; Zheng F; Fantegrossi WE
Psychopharmacology (Berl); 2022 Oct; 239(10):3237-3248. PubMed ID: 35933518
[TBL] [Abstract][Full Text] [Related]
3. Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal.
Wilson CD; Hiranita T; Fantegrossi WE
Drug Alcohol Depend; 2022 Jul; 236():109468. PubMed ID: 35643039
[TBL] [Abstract][Full Text] [Related]
4. Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.
Tai S; Hyatt WS; Gu C; Franks LN; Vasiljevik T; Brents LK; Prather PL; Fantegrossi WE
Pharmacol Res; 2015 Dec; 102():22-32. PubMed ID: 26361728
[TBL] [Abstract][Full Text] [Related]
5. Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ
Hutchison RD; Ford BM; Franks LN; Wilson CD; Yarbrough AL; Fujiwara R; Su MK; Fernandez D; James LP; Moran JH; Patton AL; Fantegrossi WE; Radominska-Pandya A; Prather PL
Front Pharmacol; 2018; 9():1084. PubMed ID: 30319418
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA.
Banister SD; Moir M; Stuart J; Kevin RC; Wood KE; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Glass M; Connor M; McGregor IS; Kassiou M
ACS Chem Neurosci; 2015 Sep; 6(9):1546-59. PubMed ID: 26134475
[TBL] [Abstract][Full Text] [Related]
7. Differential drug-drug interactions of the synthetic Cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy.
Brents LK; Zimmerman SM; Saffell AR; Prather PL; Fantegrossi WE
J Pharmacol Exp Ther; 2013 Sep; 346(3):350-61. PubMed ID: 23801678
[TBL] [Abstract][Full Text] [Related]
8. In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: inhalation versus intraperitoneal injection.
Marshell R; Kearney-Ramos T; Brents LK; Hyatt WS; Tai S; Prather PL; Fantegrossi WE
Pharmacol Biochem Behav; 2014 Sep; 124():40-7. PubMed ID: 24857780
[TBL] [Abstract][Full Text] [Related]
9. Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity.
Brents LK; Reichard EE; Zimmerman SM; Moran JH; Fantegrossi WE; Prather PL
PLoS One; 2011; 6(7):e21917. PubMed ID: 21755008
[TBL] [Abstract][Full Text] [Related]
10. Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.
Canazza I; Ossato A; Trapella C; Fantinati A; De Luca MA; Margiani G; Vincenzi F; Rimondo C; Di Rosa F; Gregori A; Varani K; Borea PA; Serpelloni G; Marti M
Psychopharmacology (Berl); 2016 Oct; 233(21-22):3685-3709. PubMed ID: 27527584
[TBL] [Abstract][Full Text] [Related]
11. Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.
Brents LK; Gallus-Zawada A; Radominska-Pandya A; Vasiljevik T; Prisinzano TE; Fantegrossi WE; Moran JH; Prather PL
Biochem Pharmacol; 2012 Apr; 83(7):952-61. PubMed ID: 22266354
[TBL] [Abstract][Full Text] [Related]
12. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?
Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL
Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047
[TBL] [Abstract][Full Text] [Related]
13. Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein-Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ
Ford BM; Cabanlong CV; Tai S; Franks LN; Penthala NR; Crooks PA; Prather PL; Fantegrossi WE
J Pharmacol Exp Ther; 2019 May; 369(2):259-269. PubMed ID: 30833484
[TBL] [Abstract][Full Text] [Related]
14. Synthetic cannabinoids JWH-018, JWH-122, UR-144 and the phytocannabinoid THC activate apoptosis in placental cells.
Almada M; Alves P; Fonseca BM; Carvalho F; Queirós CR; Gaspar H; Amaral C; Teixeira NA; Correia-da-Silva G
Toxicol Lett; 2020 Feb; 319():129-137. PubMed ID: 31730886
[TBL] [Abstract][Full Text] [Related]
15. Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors.
Cabanlong CV; Russell LN; Fantegrossi WE; Prather PL
Toxicol Sci; 2022 Apr; 187(1):175-185. PubMed ID: 35201352
[TBL] [Abstract][Full Text] [Related]
16. Synthetic Cannabinoids JWH-122 and THJ-2201 Disrupt Endocannabinoid-Regulated Mitochondrial Function and Activate Apoptotic Pathways as a Primary Mechanism of In Vitro Nephrotoxicity at In Vivo Relevant Concentrations.
Silva JP; Araújo AM; de Pinho PG; Carmo H; Carvalho F
Toxicol Sci; 2019 Jun; 169(2):422-435. PubMed ID: 30796436
[TBL] [Abstract][Full Text] [Related]
17. Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity.
Pinson A; Yarbrough AL; Bush JM; Cabanlong CV; Shoeib A; Jackson BK; Fukuda S; Gogoi J; Fantegrossi WE; McCain K; Prather PL; Fujiwara R; Radominska-Pandya A
Pharmacol Biochem Behav; 2020 Aug; 195():172949. PubMed ID: 32413436
[TBL] [Abstract][Full Text] [Related]
18. JWH-018 impairs sensorimotor functions in mice.
Ossato A; Vigolo A; Trapella C; Seri C; Rimondo C; Serpelloni G; Marti M
Neuroscience; 2015 Aug; 300():174-88. PubMed ID: 25987201
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites.
Tai S; Fantegrossi WE
Curr Top Behav Neurosci; 2017; 32():249-262. PubMed ID: 28012093
[TBL] [Abstract][Full Text] [Related]
20. 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity.
Truver MT; Watanabe S; Åstrand A; Vikingsson S; Green H; Swortwood MJ; Kronstrand R
Drug Test Anal; 2020 Jan; 12(1):127-135. PubMed ID: 31461219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]